Soho Global Health Tbk PT
IDX:SOHO

Watchlist Manager
Soho Global Health Tbk PT Logo
Soho Global Health Tbk PT
IDX:SOHO
Watchlist
Price: 1 395 IDR Market Closed
Market Cap: 17.7T IDR

Relative Value

The Relative Value of one SOHO stock under the Base Case scenario is hidden IDR. Compared to the current market price of 1 395 IDR, Soho Global Health Tbk PT is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SOHO Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
14
vs Industry
73
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
vs History
14
vs Industry
27
Median 3Y
18.9
Median 5Y
18.5
Industry
21.7
vs History
11
vs Industry
17
Median 3Y
25.6
Median 5Y
18.9
Industry
16.6
vs History
7
vs Industry
13
Median 3Y
33.8
Median 5Y
16.1
Industry
22.5
vs History
14
vs Industry
24
Median 3Y
3.2
Median 5Y
3.1
Industry
2.3
vs History
14
vs Industry
77
Median 3Y
0.8
Median 5Y
0.8
Industry
2.9
vs History
14
vs Industry
39
Median 3Y
5.3
Median 5Y
4.6
Industry
5.5
vs History
14
vs Industry
27
Median 3Y
14.4
Median 5Y
13.5
Industry
13.1
vs History
14
vs Industry
31
Median 3Y
14.4
Median 5Y
13.5
Industry
16.6
vs History
11
vs Industry
18
Median 3Y
23.3
Median 5Y
15.9
Industry
15.8
vs History
6
vs Industry
15
Median 3Y
28.5
Median 5Y
14.3
Industry
19.1
vs History
14
vs Industry
26
Median 3Y
3.2
Median 5Y
3.1
Industry
1.9

Multiples Across Competitors

SOHO Competitors Multiples
Soho Global Health Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Soho Global Health Tbk PT
IDX:SOHO
17.7T IDR 1.7 33.6 27.1 27.1
US
Eli Lilly and Co
NYSE:LLY
936.4B USD 16 51.2 34.2 36.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
503.8B USD 5.5 20 16.4 21.3
CH
Roche Holding AG
SIX:ROG
250.8B CHF 4.1 26.6 11.4 13.3
UK
AstraZeneca PLC
LSE:AZN
209.7B GBP 4.9 30 108.8 159.3
CH
Novartis AG
SIX:NOVN
201.9B CHF 4.5 17.6 11.2 14.4
US
Merck & Co Inc
NYSE:MRK
243.9B USD 3.8 12.8 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.5 9.5 11
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
146.7B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
ID
Soho Global Health Tbk PT
IDX:SOHO
Average P/E: 24.5
33.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
51.2
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.6
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30
38%
0.8
CH
Novartis AG
SIX:NOVN
17.6
17%
1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.5
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ID
Soho Global Health Tbk PT
IDX:SOHO
Average EV/EBITDA: 400.3
27.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.2
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.4
4%
2.8
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
2%
4.7
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ID
Soho Global Health Tbk PT
IDX:SOHO
Average EV/EBIT: 1 710.2
27.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.4
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3